Skip to Content
Merck
CN

29550

N-Cyclohexylsulfamic acid

≥98.0% (T)

Synonym(s):

Cyclamic acid, Cyclohexanesulfamic acid

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C6H13NO3S
CAS Number:
Molecular Weight:
179.24
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
202-898-1
Beilstein/REAXYS Number:
2208885
MDL number:
Assay:
≥98.0% (T)
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

N-Cyclohexylsulfamic acid, ≥98.0% (T)

InChI key

HCAJEUSONLESMK-UHFFFAOYSA-N

InChI

1S/C6H13NO3S/c8-11(9,10)7-6-4-2-1-3-5-6/h6-7H,1-5H2,(H,8,9,10)

SMILES string

OS(=O)(=O)NC1CCCCC1

assay

≥98.0% (T)

form

solid

mp

~180 °C (dec.)

solubility

dioxane: 1 g/10 mL, clear, colorless (hot)

Quality Level

Looking for similar products? Visit Product Comparison Guide

General description

The N-cyclohexylsulfamic acid salts of well−known therapeutic agents were prepared.

Storage Class

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Modification of physical properties of certain antitussive and antihistaminic agents by formation of N-cyclohexylsulfamate salts.
J A CAMPBELL et al.
Journal of pharmaceutical sciences, 51, 931-934 (1962-10-01)
Lin Yi et al.
Analytical and bioanalytical chemistry, 386(3), 666-674 (2006-05-26)
Characterizing the biological effects of metabolic transformations (or biotransformation) is one of the key steps in developing safe and effective pharmaceuticals. Sulfate conjugation, one of the major phase II biotransformations, is the focus of this study. While this biotransformation typically

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service